|
End-of-day quote
Shanghai S.E.
12/08/2026
|
5-day change | 1st Jan Change | ||
| 15.31 CNY | -1.42% |
|
-2.61% | +1.59% |
| 08-11 | Tasly Pharmaceutical Appoints Chair | MT |
| 07-20 | Tasly Pharmaceutical Gets China Greenlight for Stroke Drug Trial | MT |
| Market Cap | 23.05B 3.42B 2.96B 2.77B 2.53B 4.76B 326B 4.83B 32.64B 12.76B 163B 12.83B 12.56B 544B | P/E 2026 * |
17.2x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 21.79B 3.23B 2.8B 2.62B 2.39B 4.5B 308B 4.57B 30.85B 12.06B 154B 12.13B 11.87B 515B | EV / Sales 2026 * |
2.42x | EV / Sales 2027 * | 1.77x |
| Free-Float |
47.15% | Yield 2026 * |
2.92% | Yield 2027 * | 3.33% |
| 1 day | -1.42% | ||
| 1 week | -2.61% | ||
| Current month | -5.02% | ||
| 1 month | +8.74% | ||
| 3 months | +2.61% | ||
| 6 months | +3.59% | ||
| Current year | +1.59% |
| 1 week | 15.18 |  | 15.97 |
| 1 month | 14.12 | | 16.24 |
| Current year | 12.9 | | 16.24 |
| 1 year | 12.9 | | 17.69 |
| 3 years | 12.24 | | 18 |
| 5 years | 9.2 | | 18 |
| 10 years | 9.2 | | 34.22 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jin Yong Cai
CEO | Chief Executive Officer | 54 | 07/05/2024 |
Jie Wei
DFI | Director of Finance/CFO | 49 | 08/07/2018 |
Xin Yang
CIO | Chief Investment Officer | 45 | 30/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Ai Jian Wang
BRD | Director/Board Member | 72 | 01/06/2021 |
Jin Yong Cai
CHM | Chairman | 54 | 09/08/2026 |
Ke Xin Li
BRD | Director/Board Member | 58 | 07/05/2024 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.42% | -2.61% | -6.07% | +14.85% | 3.39B | |
| -0.18% | -0.86% | -9.81% | -7.24% | 13.37B | |
| -0.55% | -2.89% | +3.42% | +2.05% | 5.01B | |
| -0.04% | -0.80% | -31.72% | -56.12% | 5.06B | |
| +1.91% | +4.01% | +6.21% | -29.83% | 4.16B | |
| -0.19% | -1.55% | -13.19% | -5.97% | 3.66B | |
| -1.79% | -3.93% | -5.97% | +0.44% | 3.44B | |
| +0.44% | +1.34% | -13.09% | -15.72% | 2.48B | |
| -9.22% | -8.90% | -11.69% | +29.56% | 1.71B | |
| +1.36% | +1.36% | -29.63% | -11.90% | 1.73B | |
| Average | -0.97% | -1.51% | -11.16% | -7.99% | 4.4B | |
| Weighted average by Cap. | -0.49% | -1.08% | -10.04% | -10.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 9B 1.33B 1.16B 1.08B 988M 1.86B 127B 1.89B 12.74B 4.98B 63.72B 5.01B 4.9B 212B | 9.78B 1.45B 1.26B 1.18B 1.07B 2.02B 138B 2.05B 13.85B 5.42B 69.29B 5.45B 5.33B 231B |
| Net income | 1.36B 202M 175M 164M 149M 281M 19.25B 285M 1.93B 753M 9.64B 758M 742M 32.15B | 1.61B 238M 207M 194M 177M 332M 22.75B 337M 2.28B 890M 11.39B 895M 876M 37.98B |
| Net Debt | -1.26B -187M -162M -152M -138M -260M -17.8B -264M -1.78B -697M -8.91B -701M -686M -29.73B | -5.78B -857M -742M -695M -634M -1.19B -81.7B -1.21B -8.18B -3.2B -40.91B -3.22B -3.15B -136B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/08/26 | CN¥15.43 | +0.78% | 17,154,500 |
| 12/08/26 | CN¥15.31 | -1.42% | 17,591,043 |
| 11/08/26 | CN¥15.53 | -0.64% | 19,133,296 |
| 10/08/26 | CN¥15.63 | -0.57% | 20,773,813 |
| 07/08/26 | CN¥15.72 | +1.48% | 20,045,575 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600535 Stock
Select your edition
All financial news and data tailored to specific country editions
